Codon-specific translation reprogramming promotes resistance to targeted therapy by Rapino, Francesca, Delaunay, Sylvain, Rambow, Florian, Zhou, Zhaoli, Tharun, Lars, De Tullio, Pascal, Sin, Olga, Shostak, Kateryna, Schmitz, Sebastian, Piepers, Jolanda, Ghesquière, Bart, Karim, Latifa, Charloteaux, Benoit, Jamart, Diane, Florin, Alexandra, Lambert, Charles, Rorive, Andrée, Jerusalem, Guy, Leucci, Eleonora, Dewaele, Michael, Vooijs, Marc, Leidel, Sebastian A., Georges, Michel, Voz, Marianne, Peers, Bernard, Büttner, Reinhard, Marine, Jean-Christophe, Chariot, Alain, Close, Pierre

Get full text

Oncological patients' reactions to COVID‐19 pandemic: A single institution prospective study by Onesti, Concetta Elisa, Schroeder, Hélène, Rorive, Andrée, Sautois, Brieuc, Lecocq, Marie, Goffin, Marie, Gonne, Elodie, Collinge, Astrid, Nicolaers, Laurence, Wéra, Odile, Catot, Amandine, Loly, Catherine, Paulus, Astrid, Sibille, Anne, Lousberg, Laurence, Troisfontaine, Florence, Collignon, Joëlle, Gennigens, Christine, Frères, Pierre, Polus, Marc, Duysinx, Bernard, Vaillant, Frédérique, Marchal, Nathalie, Poncin, Aurélie, Jerusalem, Guy

Request full text

Granulomatous Reactions from Tattoos Following BRAF Inhibitor Therapy by Giet, Gabrielle, Lebas, Eve, Rorive, Andrée, Arrese, Jorge E., Nikkels, Arjen F.

Get full text

Biomarker Analysis in a Phase II Study of Sunitinib in Patients with Advanced Melanoma by Decoster, Lore, Vande Broek, Isabelle, Neyns, Bart, Majois, Françoise, Baurain, Jean François, Rottey, Sylvie, Rorive, Andrée, Anckaert, Ellen, De Mey, Johan, De Brakeleer, Sylvia, De Grève, Jacques

Get full text

The impact of COVID-19 on the new diagnoses of melanoma by Gedeah, Christophe, Damsin, Thomas, Absil, Gilles, Somja, Joan, Collins, Patrick, Rorive, Andrée, Marchal, Nathalie, Seidel, Laurence, Nikkels, Arjen F.

Get full text

Real-World Effectiveness, Safety, and Health-Related Quality of Life in Patients Receiving Adjuvant Nivolumab for Melanoma in Belgium and Luxembourg: Results of PRESERV MEL by Rogiers, Anne, Willemot, Laurence, McDonald, Laura, Van Campenhout, Hilde, Berchem, Guy, Jacobs, Celine, Blockx, Nathalie, Rorive, Andrée, Neyns, Bart

Get full text

Pre-study and in-study validation of a SPE-LC–MS–MS method for the determination of 5-S-cysteinyldopa, a melanoma biomarker, in human plasma by Martin, Gaëlle, Mansion, François, Houbart, Virginie, Paquet, Philippe, Rorive, Andrée, Chiap, Patrice, Crommen, Jacques, Servais, Anne-Catherine, Fillet, Marianne

Get full text

Chemotherapy options for patients suffering from heavily pretreated metastatic breast cancer by Jerusalem, Guy, Rorive, Andrée, Collignon, Joëlle

Get full text

Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes by Jerusalem, Guy, Rorive, Andree, Collignon, Joelle

Get full text

Author Correction: Codon-specific translation reprogramming promotes resistance to targeted therapy by Rapino, Francesca, Delaunay, Sylvain, Rambow, Florian, Zhou, Zhaoli, Tharun, Lars, De Tullio, Pascal, Sin, Olga, Shostak, Kateryna, Schmitz, Sebastian, Piepers, Jolanda, Ghesquière, Bart, Karim, Latifa, Charloteaux, Benoit, Jamart, Diane, Florin, Alexandra, Lambert, Charles, Rorive, Andrée, Jerusalem, Guy, Leucci, Eleonora, Dewaele, Michael, Vooijs, Marc, Leidel, Sebastian A., Georges, Michel, Voz, Marianne, Peers, Bernard, Büttner, Reinhard, Marine, Jean-Christophe, Chariot, Alain, Close, Pierre

Get full text

Recurrent In Situ Melanoma Successfully Treated with Ingenol Mebutate by Mansuy, Marion, Nikkels-Tassoudji, Nazli, Arrese, Jorge E., Rorive, Andree, Nikkels, Arjen F.

Get full text

Granulomatous Reactions from Tattoos Following BRAF Inhibitor Therapy by Giet, Gabrielle, Lebas, Eve, Rorive, Andrée, Arrese, Jorge E, Nikkels, Arjen F

Get full text